Delisting risk
PRF Technologies (PRFX)
Develops sustained-release therapies and software for solar-asset monitoring and optimization.
$0.9600
Pre-market+0.01 (+1.02%)
At close$0.9503(−0.09%)
In millions of USD, except per-share figures
| In millions | Q1 FY23Mar 2023 | Q2 FY23Jun 2023 | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | — | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | 2 | 1 | 4 | 6 | 7 | 1 | 1 | 1 | 1 | 1 | 5 | |
| Research & development | 1 | 1 | 1 | 3 | 5 | 7 | 0 | 0 | 0 | 0 | 0 | 1 |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Operating income | −2 | −2 | −1 | −4 | −6 | −7 | −1 | −1 | −1 | −1 | −1 | −5 |
| 0 | 0 | 1 | −1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | — | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −2 | −2 | 0 | −5 | −6 | −7 | −1 | −1 | −1 | −1 | −1 | −5 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −2 | −2 | 0 | −5 | −6 | −7 | −1 | −1 | −1 | −1 | −1 | −5 |
| Net income | −2 | −2 | 0 | −5 | −6 | −7 | −1 | −1 | −1 | −1 | −1 | −5 |
| EPS, basic | −$1,291.68 | −$1,220.58 | $19.81 | −$2,096.26 | −$1,630.41 | −$1,264.96 | −$15.00 | −$15.00 | −$13.75 | −$13.75 | −$1.45 | −$7.47 |
| EPS, diluted | −$1,291.68 | −$1,220.58 | $19.81 | −$2,096.26 | −$1,630.41 | −$1,264.96 | −$15.00 | −$15.00 | −$13.75 | −$13.75 | −$1.45 | −$7.47 |
| Weighted average shares, basic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Weighted average shares, diluted | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| EBITDA | −2 | −2 | −1 | −4 | −6 | −7 | −1 | −1 | −1 | −1 | −1 | −4 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| EBIT | −2 | −2 | −1 | −4 | −6 | −7 | −1 | −1 | −1 | −1 | −1 | −5 |